Exagen Expects 3Q23 Revenue Of $10M-$10.5M Vs. Consensus Of $11.76M
Portfolio Pulse from Benzinga Newsdesk
Exagen Inc. has provided its revenue guidance for the third quarter of 2023, expecting to generate between $10 million to $10.5 million. This is lower than the consensus estimate of $11.76 million.
August 07, 2023 | 12:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Exagen's projected 3Q23 revenue is lower than the consensus estimate, which could negatively impact investor sentiment.
Exagen's projected revenue for 3Q23 is lower than the market consensus. This could lead to a negative reaction from investors, potentially driving the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100